Friday April 12th, 2019
Thank you to everyone who invested in Amnion Life. We have been busy working on the development of our flagship product, AmnioBed. In fact I'm writing to you on the tail-end of an exciting month here at Amnion Life. On Friday, March 29th, I had the honor of representing the company as one of 13 finalists at the UCSF-Stanford Pediatric Device Consortium 2019 pitch competition. I presented the sophisticated technology behind the AmnioBed, our neonatal intensive care unit incubator designed specifically for preterm birth (PTB) infants. I'm thrilled to announce that we took home the Gold Award. This is a testament to the innovation behind our product and the significant need in the neonatal care landscape for better pediatric medical devices.
Our mission is to develop novel devices such as the AmnioBed. This has the potential to decrease morbidity and mortality in preterm birth (PTB) infants, reduce healthcare costs, and revolutionize preterm birth (PTB) infant care. Click here to learn more
We rely on the support of our investors to accomplish this critical work. Since our founding, we have raised over $1.2 million. This has enabled us to secure U.S. and international patents, build our Research & Development facility, and develop a prototype for pre-clinical testing.
You have a chance to join this challenging yet important endeavor.
Our crowdfunding campaign on Wefunder is ending on April 15th.
Thank you for your interest and support. The team here at Amnion Life is passionate and dedicated, and we are proud to be spearheading the effort to improve the lives of PTB infants.
CEO & Founder, Amnion Life
Privacy: We won’t share your data, or post to your wall, without your permission.
Already have a Wefunder account? Login
Don't have a Wefunder account? Signup